In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma
Kunbin Ke; Hongjian Li; Hong Yao; Xi‐Nan Shi; Chao Dong; Ying Zhu; Xu Liu; Ling Li; Kwong‐Sak Leung; Man‐Hon Wong; Xiao‐Dong Liu; Hsiang‐fu Kung; Marie Chia‐mi Lin
Author Information: Biomedical Engineering Research Center
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.